Specifically, it has been shown that the WNT5A-mediated suppression of CD44 reduces the downstream AKT signaling, which further explains how WNT5A signaling impairs breast cancer cell migration and invasion [39]. The gene discussed is WNT5A; the disease is breast cancer.